Bio
Joined in September 2007 from ITI Life Sciences and is responsible for the White Rose Technology Seedcorn Fund, an early stage seed fund which invests in new technology emerging from the universities of Leeds, Sheffield and York. Previously worked as a scientist with GlaxoSmithKline and then as a clinical pharmacist at Guy’s/St Thomas’ hospitals, London. After completing a PhD, moved to international consultancy firm Wood Mackenzie (and then parent Deutsche Bank) where he supported the healthcare banking team, advising clients on their corporate and licensing strategies and performing due diligence projects on companies, products and technologies. Most recently at ITI Life Sciences, a unique state-supported innovation fund, was responsible for identifying funding opportunities and crafting these into significant collaborative R&D programs. First Class Honours degree in Pharmacy, a PhD (Molecular Biology/Gene Delivery) from the University of Bath and a MBA with distinction from Edinburgh University.
Career
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Maven Capital Partners UK LLPMaven Capital Partners is an independent private equity businessEmail: [email protected] |